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GH4C, cells (GH cells) are a clonal strain of rat pituitary tumor cells which secrete prolactin.
GH cells have been used to study hormone secretion, but they store relatively little prolactin
compared to normal prolactin-secreting cells. They are not suitable, therefore, for studying
some aspects ofpituitary function. We have found that the amount of prolactin GH cells store
can be regulated. When GH cells were plated at 106 cells/well and treated for six days with
180 nM insulin or 1 nM estradiol, there was a 60 percent increase in prolactin storage compared
to control cells. Insulin and estradiol in combination acted synergistically to cause a 190 per-
cent increase in prolactin storage. In contrast, they were additive in increasing extracellular
prolactin; there was a 40 percent increase in extracellular prolactin after insulin, a 20 percent
increase after estradiol, and a 50 percent increase after insulin plus estradiol. The increases in
prolactin storage were always greater than the increases in extracellular prolactin. The in-
creases in prolactin storage were dose-dependent and reached maximal levels after four days of
treatment with 180 nM insulin plus I nM estradiol. Reducing the plating density to 103
cells/well increased the response to insulin and estradiol to nineteenfold. Epidermal growth
factor (10 nM) acted synergistically with estradiol and insulin in combination to increase pro-
lactin storage 27-fold.
The insulin- and estradiol-induced increase in extracellular prolactin was caused by a specific
increase in the rate of prolactin synthesis. The fractional increase in prolactin storage above
the increase in prolactin production could not be explained by an increase in prolactin syn-
thesis, an increase in intracellular transit time, or a change in the cell-cycle distribution of the
population. Hormone storage can, therefore, be regulated independently from other processes
which control hormone production.
The prolactin stored in response to insulin and estradiol was releasable by potassium
depolarization. Following depletion of intracellular prolactin by depolarization, the cells re-
tained their increased capacity for prolactin storage. The ability to increase prolactin storage
will make GH cells a more useful system in which to study pituitary function.
INTRODUCTION
The GH3 rat pituitary tumor cell line was established in 1968 and has retained the
ability to synthesize and secrete prolactin and growth hormone in vitro [1,2]. Since
that time, GH3 cells (GH cells) have been used extensively to study prolactin secre-
tion in vitro. GH cells are a clonal strain and offer the advantage of consisting of a
single cell type which can be propagated indefinitely in vitro. GH cells, however,
store a much smaller proportion ofthe prolactin than they secrete compared to nor-
mal prolactin-secreting cells; they also lack the typical dense secretory granules seen
in electron micrographs of normal mammotrophs [3,4]. Although GH cells have re-
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tained some properties of the differentiated cell, i.e., prolactin synthesis and secre-
tion, the lack of mature secretory granules and the relatively low intracellular levels
ofprolactin indicate that they have a reduced capacity for prolactin storage and that
transformation has disturbed the normal pathways involved in the storage process.
No studies have focused on changes in prolactin storage and very few have even
reported intracellular prolactin levels. Increasing GH cell prolactin storage may
make them suitable for studying pituitary function.
We tested the classical differentiating agents dimethylsulfoxide, isobutylmethyl-
xanthine, butyrate, and insulin for their ability to induce increases in prolactin
storage in GH cells. In addition, estradiol was tested because Haug et al. [5,61
demonstrated that it increases intracellular prolactin and prolactin production in
GH cells. Of these agents, insulin and estradiol increased prolactin storage in our
studies. The following report is a review ofour characterization ofthis effect. In ad-
dition to previously reported data, we include recent results which have clarified our
former findings.
METHODS
Culture medium and serum were from Grand Island Biological Co. (Grand
Island, NY). Dr. A.F. Parlow of the hormone distribution program ofthe National
Institute of Arthritis, Metabolism, and Digestive Disease (Bethesda, MD) supplied
rat prolactin used for production ofrabbit antiserum and as a standard for prolactin
assays. Bovine pancreatic insulin and 17,B-estradiol were from Sigma Chemical Co.
(St. Louis, MO). Protein A bacterial adsorbant was from Miles Laboratories, Inc.
(Elkhart, IN). L-[4,5-3H]leucine was from New England Nuclear and L-[4CJleu-
cine was from Schwarz/Mann (Orangeburg, NY).
Cell Culture
GH4C1 cells were grown as monolayers in Ham's FIO medium supplemented with
15 percent horse serum and 2.5 percent fetal bovine serum (F10+). Cultures were
plated in 35 mm wells in a volume of 1 or 1.5 ml. We obtained the same results with
either volume. Two days after plating, control cells received fresh medium and
treated cells received fresh medium containing the indicated concentrations of in-
sulin and estradiol. Fresh medium and hormones were applied every two days for six
or eight days unless otherwise indicated.
Measurement ofProlactin and Cell Number
GH cells were collected and cell number was determined using a Coulter Counter
(Coulter Electronics, Inc., Hialeah, FL) as previously described [7]. We measured
prolactin released into the medium and intracellular prolactin in cell sonicates by
microcomplement fixation [2,8]. Prolactin is reported in yg/106 cells or as the ratio
of hormone-treated levels to control levels after normalization to cell number. Each
treatment was performed in triplicate; the variation among samples was less than 10
percent. We used analysis ofvariance followed by the protected least significant dif-
ference to analyze the data statistically; all comparisons of hormone-treated to con-
trol mentioned in the text are significant (p >0.05) unless otherwise specified.
Double-Isotopic Measurement ofInsulin- and Estradiol-Induced
Changes in Prolactin Synthesis
GH cells were grown six days in the presence or absence of 300 nM insulin plus I
nM estradiol. One to two hours before addition of radiolabeled leucine, fresh FO+
410REGULATION OF PROLACTIN STORAGE
containing 15 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)
and fresh hormones was added to the cells. Hormone-treated cells were incubated
three hours with 10 ACi ['4C]leucine (312 mCi/mmole) and control cells were in-
cubated with 10 jCi [3H]leucine (2 Ci/mmole). Cells from control wells and
hormone-treated wells were combined and sonicated. Incorporation of radiolabeled
leucine into prolactin was determined by immunoadsorption onto S. aureus protein
A as described by Kessler [9] followed by electrophoresis on SDS 13 percent
polyacrylamide cylindrical gels [10]. The incorporation of radiolabeled leucine into
acid-precipitable proteins was determined on 0.2 ml fractions of the sonicates which
were precipitated in 10 percent trichloroacetic acid (TCA). The ratio of 14C to 3H
was determined for the prolactin and acid-precipitable proteins distributed along
each gel.
Potassium Depolarization of GH Cells
GH cells were grown six days in the presence and absence of 300 nM insulin plus 1
nM estradiol. We replaced the medium with 1 ml of fresh FIO+ with and without
hormones plus 50 mM K+ or an equimolar excess of Na+. After a 20-minute incuba-
tion at 37°C, prolactin released into the medium and remaining in the cells was
measured.
Recovery ofIntracellular Prolactin after Potassium Depolarization
GH cells were grown and depolarized for 20 minutes as described above. Follow-
ing the depolarization period, we replaced the medium with fresh medium with and
without hormones containing normal Na+ and K+ concentrations. Intracellular pro-
lactin was measured two and four hours later.
RESULTS
Insulin and Estradiol Increase Intracellular and Extracellular Prolactin
in GH Cells
GH cells grown six days in the presence of insulin, estradiol, or insulin and
estradiol together showed increases in intracellular and extracellular prolactin com-
pared to control cells grown in Ham's F1O+ medium alone. The results of several
experiments are summarized and shown in Fig. 1. There was a 60 percent increase in
intracellular prolactin after 180 nM insulin, a 60 percent increase after 1 nM
estradiol, and a 190 percent increase above control values after insulin and estradiol
together. Extracellular prolactin increased 40 percent with insulin, 20 percent with
estradiol, and 50 percent with insulin and estradiol together. The effects ofinsulin or
estradiol alone on intracellular and extracellular prolactin were not statistically
significant in every experiment; when insulin and estradiol were used in combination,
the increases in intracellular and extracellular prolactin were always significant. The
effects of insulin and estradiol together on extracellular prolactin were additive, but
insulin and estradiol acted synergistically to increase intracellular prolactin.
Insulin and Estradiol Slow GH Cell Growth
There were fewer cells per tissue-culture well after six days of treatment with in-
sulin, estradiol, or insulin plus estradiol (Fig. 1). Insulin or estradiol alone decreased
cell number 10 to 20 percent and the two hormones together decreased cell number
25 to 30 percent. The decreases seen with either hormone alone were not always
statistically significant. The reduced cell number after hormone treatment resulted
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FIG. 1. Effects ofinsulin, estradiol,
and insulin plus estradiol on prolactin
and cell number. GH cells were plated
at 106 cells/35 mm tissue-culture well
and treated for six days with 180 nM
insulin, 1 nM estradiol, or insulin and
estradiol together. Each bar represents
the mean of several independent ex-
periments, the number of which are
indicated within each bar. Measure-
ments ofintracellular and extracellular
prolactin were normalized to cell
> F number before the ratio of hormone-
treated to controls was calculated.
Control values averaged 0.86 fig/106
cells for intracellular prolactin, 15.7
CELL tg/(106 cells 48 hours) for extracellular
NUMBER prolactin, and 2.75 x 106 cells/well.
from both a decreased rate of proliferation and a reduction in final density that the
cells reach at plateau [7]. GH cells do not become confluent at plateau density; they
grow in small clumps, piled on top of each other, that never completely cover the
plates.
The Effects ofInsulin and Estradiol Are Concentration-Dependent
The insulin- and estradiol-induced increases in intracellular and extracellular pro-
lactin and the decrease in cell number are concentration-dependent [7]. The dose
responses for all three effects are similar. The half-maximal concentration ofinsulin
is about 2 x 10-8M and the half-maximal concentration of estradiol is about
5 x 10-1"M. The half-maximal concentration of insulin is not affected by the
presence of estradiol and the half-maximal concentration ofestradiol is not affected
by the presence of insulin.
Time Courses of the Effects ofInsulin and Estradiol
Figure 2 shows that maximal storage and growth responses to insulin plus
estradiol occurred after four days of treatment. Maximal extracellular responses oc-
curred after six days. When insulin and estradiol were used alone, similar time
courses were seen.
Insulin and Estradiol Increase the Rate ofProlactin Synthesis
Insulin- and estradiol-induced increases in intracellular and extracellular prolactin
could be due to a hormone-induced increase in the rate of prolactin synthesis or a
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decrease in its rate of degradation. Previous reports showed that GH cells do not
degrade prolactin under normal conditions [11] so it was likely that insulin and
estradiol were increasing prolactin synthesis. We measured the rate of [3H]leucine
incorporation into prolactin over a 180-minute period in GH cells which had been
treated six days with estradiol plus insulin [7]. The incorporation of [3H]leucine into
prolactin was increased 60 percent by insulin and estradiol. If this increase reflects
an increase in prolactin synthesis, it would account for the 40 percent increase in ex-
tracellular prolactin measured in the same experiment. The increased rate of
[3H]leucine incorporation into prolactin, however, may not have accurately re-
flected a specific increase in prolactin synthesis. In those studies, free intracellular
[3H]leucine and the rate of its incorporation into acid-precipitable proteins was also
increased by hormone treatment about 50 percent. Since insulin has been shown to
increase cellular amino-acid transport in other systems [12], it was possible that the
increased rate of [3H]leucine incorporation into prolactin was due to an increase in
the specific activity of intracellular leucine rather than an increase in the rate of pro-
lactin synthesis. It is also possible that, if there was an increase in prolactin syn-
thesis, it was a result ofan overall increase in protein synthesis and not an effect spe-
cific for prolactin.
We used double-isotopic labeling to determine whether insulin and estradiol treat-
ment specifically increase prolactin synthesis. After six days of hormone treatment,
[3H]leucine was added to control cells and [14C]leucine was added to hormone-
treated cells for a 180-minute period. Control cells and treated cells were combined
after the labeling period. Prolactin immunoprecipitates and acid-precipitable pro-
teins from the combined samples were subjected to SDS polyacrylamide gel elec-
trophoresis. The gels were sliced and the 14C/3H ratio determined for prolactin from
the immunoprecipitates and for cellular proteins distributed along the gels of the
acid precipitates. Any protein whose synthesis is preferentially increased by hor-
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mone treatment should show an increase in the '4C/3H ratio compared to other pro-
teins. A representative gel is shown in Fig. 3; the 14C/3H ratio is specifically in-
creased for prolactin as well as for a few other unidentified cellular proteins. Similar
results are obtained for prolactin immunoprecipitates and acid precipitates from GH
cells treated with insulin or estradiol alone. When the isotopes were reversed, i.e.,
control cells received ['4C]leucine and treated cells received [3H]leucine, the 14C/3H
ratio is specifically decreased for prolactin (not shown). We conclude from these
studies insulin and estradiol specifically increase prolactin synthesis. The increase in
prolactin synthesis is enough to account for the increase in extracellular prolactin
but is not enough to account for the increase in prolactin storage.
Insulin and Estradiol Do Not Increase the Intracellular Transit Time ofProlactin
The intracellular transit time for prolactin is the time it takes for newly synthesized
prolactin to be processed for release from the celt. Ifinsulin and estradiol treatment
increased prolactin intracellular transit time, the cells would contain moreprolactin.
Insulin and estradiol did not affect the time it took for [3H]prolactin to appear in the
medium after the addition of [3Hlleucine (45 to 60 minutes) and so do not increase
prolactin storage by increasing its intracellular transit time [7].
Insulin and Estradiol Do Not Affect the Cell-Cycle
Distribution of the Cell Population
We stained GH cells specifically for prolactin using an indirect immunofluores-
cent technique and for DNA using the fluorescent dye propidium iodide. Flow
microfluorometric analysis of the doubly stained cells indicated that prolactin
storage increased as GH cells passed from the cell-cycle compartments G2 to
G2 + M [13]. This was consistent with work by Hoyt and Tashjian [14] showing
that GH cells are heterogeneous with respect to prolactin content. Insulin and
PRL
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o TCA PRECIPITATE
1.4-
FIG. 3. The ratio of 14C to3H along
14 1SDS 13 percentpolyacrylamidegels of
3H 4acid-precipitable proteins (0) and a H prolactin immunoprecipitate (0 ).
1.2 O GH cells plated at 106 cells/well and
treated six days with 300 nM insulin
plus 1 nM estradiol were incubated for
180 minutes with 10 uCi [14C]leucine
and their controls were incubated with
1.0 10 ACi [3H]leucine. Control and
treated cells were then combined. We
prepared trichloroacetic acid precip-
itates and prolactinimmunoprecipitates
from the pooled sonicates and ran
.8
each on a separate SDS gel. The posi-
0 5 10 15 20 25 30 tion of the prolactin peak in the im-
Top Bottom munoprecipitate is indicated by the
SL ICE NUMBER bar.
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estradiol could increase prolactin storage by increasing the proportion of cells in
G2 + M. The cell-cycle distributions of GH cells treated with insulin, estradiol, or
insulin and estradiol in combination were, however, identical to untreated GH cells
[13]. This confirms findings by Clausen and co-workers [151 that estradiol does not
influence GH cell cell-cycle distribution.
Hormone-Induced Increases in Prolactin Storage Are Cell-Density Dependent
In most of our studies, cells were routinely plated at initial densities of 106 or 105
cells/35 mm tissue-culture well. We have since found that an enhanced response to
insulin and estradiol occurs in cells plated at lower initial densities (Table 1). Prolac-
tin storage increased twofold in cells plated at 2 x 106 cells/well and nineteenfold in
cells plated at 103 cells/well. The effect of hormone treatment on extracellular pro-
lactin was less than the effect on prolactin storage at all cell densities tested produc-
ing twofold increases at most (not shown). We do not know the basis for the de-
creased response at high cell density but it does not appear to be caused by depletion
ofhormones or nutrients from the medium or the production ofan inhibitory factor
by the cells because the response to hormones is not affected by growing cells in
volumes of medium ranging from 0.5 to 5.0 ml.
Hormone-Induced Stored Prolactin Is Released by Stimulation
High extracellular concentrations of K' depolarize GH cells [16] and result in a
calcium-dependent stimulation of prolactin release [17,18]. Figure 4A shows that
prolactin stored in response to insulin and estradiol was also released by K+
depolarization. Incubation for 20 minutes in medium containing 50 mM K'
stimulated release from untreated cells about 60 percent and from hormone-treated
cells about 140 percent compared to cells incubated in medium containing an
equimolar excess of Na'. This extra amount of Na' did not stimulate release com-
pared to medium containing normal Na' concentrations (data not shown). The
amount of prolactin remaining in the cells after depolarization is reduced 60 percent
in control cells and 70 percent in hormone-treated cells, compared to nondepolarized
cells.
Insulin- andEstradiol-Treated GH Cells Retain Their Increased
Capacityfor Prolactin after Its Depletion by Stimulation
Data in Fig. 4B show the recovery ofintracellular prolactin levels after release was
stimulated by depolarization. After incubation with excess K+ for 20 minutes, intra-
TABLE I
Effect of Initial Plating Density on Hormone-Induced Prolactin Storage
Intracellular Prolactin
Initial Density Control Insulin + E2 Hormone-Treated/
(cells per well) (jug/107 cells SE) Control
103 4.8 0.24 93 7.4 19
104 2.2 + 0.11 31 + 1.9 14
105 5.0 + 0.18 12 + 0.4 2.4
2 x 106 6.1 0.03 12 1.1 2.0
Note: GH cells were plated at the indicated initial densities in 35 mm tissue-culture wells. After eight
days of treatment with 300 nM insulin plus 1 nM estradiol, intracellular prolactin was measured as de-
scribed in "Materials and Methods."
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FIG. 4. Basal and potassium-stimulated prolactin release from control and hormone-treated GH cells.
GH cells plated at l01 cells/well were grown six days with and without 300 nM insulin + 1 nM estradiol.
A. Medium was replaced with FlIO+ with and without hormones containing 45 mM excess Na4 (Na4) or
45 mM excess K4 (K4). We measured the amount of prolactin released into the medium during the subse-
quent 20 minutes and the amount ofprolactin remaining in the cells. B. After the 20-minute incuba-
tion, fresh medium containing normal concentrations of Na+ and K+ replaced the medium containing ex-
cess Na+ or K+. Intracellular prolactin was measured during the subsequent four hours for control cultures
(no hormones, *, 0) and hormone-treated cultures (A A). Closed symbols represent cultures which
were previously incubated with excess Na+; open symbols represent cultures which were incubated with
excess K+. Each point is the mean of triplicate wells 4 SE.
cellular hormone was depleted, compared to cells treated with excess Na+ (O time in
Fig. 4). Prolactin storage returned to 90 percent of unstimulated levels by four hours
in hormone-treated cells. This is in contrast to the four days of hormone treatment
required to reach this level of storage initially (Fig. 2). This indicates that hormone-
treated GH cells retain their increased capacity for prolactin storage even after it has
been depleted by acute stimulation with high concentrations of K+.
The Presence of the Hormones Is Required to Maintain the Increased Storage
Data in Fig. 5 show that removing insulin and estradiol from the medium after
eight days of hormone treatment results in a decrease in induced prolactin storage.
Intracellular prolactin levels drop 50 percent two days after hormone removal. Eight
days after hormone removal, however, prolactin storage remains increased twofold
over cells which received control medium for the entire 16-day period. Longer time
periods were not tested so we do not know ifprolactin storage would have eventually
reached control levels. Induced prolactin storage in cells treated the entire 16 days
with insulin and estradiol also decreased during the last eight days but not as rapidly
as in cultures from which hormones were removed.
Epidermal Growth Factor Enhances the Response ofProlactin
Storage to Insulin and Estradiol
A report by Schonbrunn and co-workers [19] showed that epidermal growth fac-
tor (EGF) increased prolactin synthesis, decreased cell growth, and increased cell
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volume in GH cells. These effects are qualitatively similar to effects of insulin and
estradiol which we have observed, but the effects of EGF on intracellular prolactin
were not reported. We measured prolactin storage in cells treated with EGF alone
and in combination with insulin and estradiol. Data in Fig. 6 show that 10 nM EGF
alone increased intracellular prolactin fivefold. Insulin did not affect the response to
EGF. In contrast, estradiol and EGF acted synergistically to increase prolactin
storage twentyfold. Although insulin did not affect the response to EGF alone, it
enhanced the response to EGF and estradiol in combination producing a twenty-
seven-fold increase. These synergistic responses were specific for intracellular pro-
lactin since EGF alone increased extracellular prolactin fivefold, but insulin,
estradiol, or insulin and estradiol in combination did not enhance this effect, pro-
ducing fivefold increases in each case.
DISCUSSION
GH cells, like many human adenomas, synthesize and secrete large amounts of
prolactin but store very little [20]. We have shown that the amount of prolactin
stored can be affected by at least three hormones. We are not aware of any other
studies that show the amount ofhormone a cell contains is not just a function of the
synthesis and release of that hormone but can be independently regulated. This
regulation is obviously complex, since we found three hormones can affect storage,
and some combinations of hormones act synergistically. The synergy suggests each
hormone may affect a separate step to increase prolactin storage and production. It
is not known what determines the storage capacity of prolactin cells. There are
macromolecules other than prolactin associated with prolactin storage granules in
normal mammotrophs [21,22] and it is possible that effects on these molecules may
influence prolactin storage.
Both insulin and estradiol inhibited cell growth to a small extent. This effect is
surprising since insulin is a mitogen in most cell cultures [23] and estrogens ad-
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Our original objective was to increase prolactin storage in GH cells to make them
more suitable for studying pituitary function. By plating cells at low densities we are
able to increase prolactin storage up to nineteenfold. Prolactin stored in response to
hormone treatment is released by potassium stimulation. Using this system, we have
recently determined that GH cells maintain functionally distinct prolactin poolsREGULATION OF PROLACTIN STORAGE 419
similar to those demonstrated in normal mammotrophs [28]. These pools are af-
fected differently by potassium stimulation. Similar investigations should be possi-
ble using prolactin-release inhibitory agents and may elucidate mechanisms involved
in prolactin regulation.
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